To be a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life.
CHIEF TECHNOLOGY OFFICER
Dr Matthew J Baker
Inventor with 18+ years’ experience in the field of clinical spectroscopy. Top 6 KMPG Best British Tech Pioneers (2020), Fellowship of the Society for Applied Spectroscopy (2020), Top 40 under 40 Analytical Scientists (2018), RSC Harrison Meldola Prize (2017) and Emerging Leader in Molecular Spectroscopy (2016).
CHIEF EXECUTIVE OFFICER
Dr Mark Hegarty
20+ years' experience in startups and healthcare products, successfully building international B2B sales and relationships across 20+ countries.
Previously led Daysoft Limited from zero to £10m sales per annum, realizing an initial £3m return to investors and creating 220 jobs. Formerly was Operations Manager of Scherer Drug Delivery Systems which was acquired by Cardinal Health and is now a Catalent company.
HEAD OF DEVELOPMENT
Dr Holly J Butler
11+ years' experience in the clinical spectroscopy field. 'Young Entrepreneur' of the year winner, 2017 – Scottish Women's Awards 'Women in Innovation' winner, 2017 – Global Game Changers Awards Experienced post-doctoral researcher in biophotonics and infrared analysis.
Professor Steven Howell
Highly experienced Chair and serial entrepreneur, having commercialized 10 products in diagnostics and healthcare. Formerly held senior positions in Alere and Inverness Medical.
Dr Andrew McNeill
Andrew McNeill is Managing Partner at Eos Advisory. He has over 15 years’ experience in leading early-stage venture capital backed medical device and biotech companies.
Dr Stephen Little
Strong track record as a diagnostics leader. Former Founder & CEO of DxS (sold to Qiagen for $130M), former R&D Manager Astra Zeneca Diagnostics, and current Vice Chairman at Yourgene Health.
Professor David Onions
Representing Norcliffe Capital Limited, Prof Onions has extensive experience in growing and commercializing businesses in the Life Sciences and Biotech sector.
SCIENTIFIC ADVISORY BOARD
READER & HONORARY CONSULTANT NEUROSURGEON
Dr Paul Brennan, MB BChir PhD FRSC (SN)
Reader and Consultant Neurosurgeon at the University of Edinburgh and NHS Lothian. Strong track record leading clinical trials and laboratory research, with major focus on brain tumors. Experience as med-tech medical advisor, and founder of university spin-out eoSurgical Ltd providing surgical simulation training around the world.